Peter C. Maple-Chris

Nottingham, ENG NG72UH, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Human Alpha Herpesviruses Infections (HSV1, HSV2, and VZV), Alzheimer's Disease, and the Potential Benefits of Targeted Treatment or Vaccination-A Virological Perspective.

Human Alpha Herpesviruses Infections (HSV1, HSV2, and VZV), Alzheimer's Disease, and the Potential Benefits of Targeted Treatment or Vaccination-A Virological Perspective.

Journal: Vaccines
Published: April 16, 2025

COVID-19, SARS-CoV-2 Vaccination, and Human Herpesviruses Infections.

COVID-19, SARS-CoV-2 Vaccination, and Human Herpesviruses Infections.

Journal: Vaccines
Published: December 25, 2022

Herpesvirus Vaccines.

Herpesvirus Vaccines.

Journal: Vaccines
Published: April 07, 2022

Multiple Sclerosis, Viruses, and New Vaccines.

Multiple Sclerosis, Viruses, and New Vaccines.

Journal: Neurology international
Published: November 29, 2021

Population (Antibody) Testing for COVID-19-Technical Challenges, Application and Relevance, an English Perspective.

Population (Antibody) Testing for COVID-19-Technical Challenges, Application and Relevance, an English Perspective.

Journal: Vaccines
Published: April 10, 2021

An Absence of Epstein-Barr Virus Reactivation and Associations with Disease Activity in People with Multiple Sclerosis Undergoing Therapeutic Hookworm Vaccination.

An Absence of Epstein-Barr Virus Reactivation and Associations with Disease Activity in People with Multiple Sclerosis Undergoing Therapeutic Hookworm Vaccination.

Journal: Vaccines
Published: July 30, 2020

How Useful is COVID-19 Antibody Testing - A Current Assessment for Oncologists.

How Useful is COVID-19 Antibody Testing - A Current Assessment for Oncologists.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: June 19, 2020

Cytomegalovirus and Epstein-Barr Virus Associations with Neurological Diseases and the Need for Vaccine Development.

Cytomegalovirus and Epstein-Barr Virus Associations with Neurological Diseases and the Need for Vaccine Development.

Journal: Vaccines
Published: December 31, 2019

A different response to cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infection in UK people with multiple sclerosis (PwMS) compared to controls.

A different response to cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infection in UK people with multiple sclerosis (PwMS) compared to controls.

Journal: The Journal of infection
Published: May 10, 2019

Viral load and antibody boosting following herpes zoster diagnosis.

Viral load and antibody boosting following herpes zoster diagnosis.

Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: November 20, 2017

Differentiation between wild-type and vaccines strains of varicella zoster virus (VZV) based on four single nucleotide polymorphisms.

Differentiation between wild-type and vaccines strains of varicella zoster virus (VZV) based on four single nucleotide polymorphisms.

Journal: Epidemiology and infection
Published: July 28, 2017

The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antibody-to-membrane-antigen assay (FAMA), VZV time-resolved fluorescence immunoassay and a VZV purified glycoprotein enzyme immunoassay.

The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antibody-to-membrane-antigen assay (FAMA), VZV time-resolved fluorescence immunoassay and a VZV purified glycoprotein enzyme immunoassay.

Journal: Epidemiology and infection
Published: March 29, 2016
Showing 1-12 of 23

Last Updated: 09/26/2026